{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:57:54Z","timestamp":1793149074163,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Science and Technology of China","award":["2009ZX10004-312"],"award-info":[{"award-number":["2009ZX10004-312"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271885"],"award-info":[{"award-number":["81271885"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.antiviral.2014.03.020","type":"journal-article","created":{"date-parts":[[2014,4,5]],"date-time":"2014-04-05T21:02:06Z","timestamp":1396731726000},"page":"116-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Inhibition of hepatitis C virus infection by NS5A-specific aptamer"],"prefix":"10.1016","volume":"106","author":[{"given":"Xiaoyan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haizhen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.03.020_b0005","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/JVI.05696-11","article-title":"Formation of higher-order foot-and-mouth disease virus 3Dpol complexes is dependent on elongation activity","volume":"86","author":"Bentham","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.020_b0010","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","article-title":"High permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication","volume":"76","author":"Blight","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.020_b0015","doi-asserted-by":"crossref","first-page":"8237","DOI":"10.1093\/nar\/gkr381","article-title":"Broad-spectrum aptamer inhibitors of HIV reverse transcriptase closely mimic natural substrates","volume":"39","author":"Ditzler","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2014.03.020_b0020","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In vitro selection of RNA molecules that binds specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.03.020_b0025","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature08960","article-title":"Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect","volume":"465","author":"Gao","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.03.020_b0030","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jhep.2011.01.011","article-title":"Hepatitis C virus resistance to protease inhibitors","volume":"55","author":"Halfon","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2014.03.020_b0035","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1056\/NEJMct061675","article-title":"Peginterferon and ribavirin for chronic hepatitis C","volume":"355","author":"Hoofnagle","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.03.020_b0040","doi-asserted-by":"crossref","first-page":"10788","DOI":"10.1128\/JVI.02406-08","article-title":"A conserved praline between domain II and III of hepatitis C virus NS5A influences both RNA replication and virus assembly","volume":"83","author":"Hughes","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.020_b0045","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1093\/nar\/gkr1098","article-title":"5\u2032-Triphosphate- RNA-independent activation of RIG-I via RNA aptamer with enhanced antiviral activity","volume":"40","author":"Hwang","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2014.03.020_b0050","doi-asserted-by":"crossref","first-page":"8987","DOI":"10.1128\/JVI.00004-12","article-title":"Cell culture-adaptive mutations promote viral protein\u2013protein interactions and morphogenesis of infectious hepatitis C virus","volume":"86","author":"Jiang","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.020_b0055","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.antiviral.2014.03.020_b0060","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1128\/JVI.02156-10","article-title":"Regulation of the production of infectious genotype 1a hepatitis C virus by NS5A domain III","volume":"85","author":"Kim","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.020_b0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Laucer","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.03.020_b0070","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.03.020_b0075","doi-asserted-by":"crossref","first-page":"7964","DOI":"10.1128\/JVI.00826-08","article-title":"Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles","volume":"82","author":"Masaki","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.020_b0080","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1074\/jbc.M110.178426","article-title":"Protection of HIV neutralizing aptamers against rectal and vaginal nucleases: implications for RNA-based therapeutics","volume":"286","author":"Moore","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.03.020_b0085","first-page":"5","article-title":"New antiviral agents for hepatitis C. F1000","volume":"4","author":"Pawlotsky","year":"2012","journal-title":"Biol. Rep."},{"key":"10.1016\/j.antiviral.2014.03.020_b0090","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1128\/JVI.02626-09","article-title":"RNA aptamers directed to human immunodeficiency virus type 1 Gag protein bind to matrix and nucleocapsid domains and inhibit virus production","volume":"85","author":"Ramalingam","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.020_b0095","first-page":"117","article-title":"New insights into HCV replication: potential antiviral targets","volume":"19","author":"Rice","year":"2011","journal-title":"Top. Antivir. Med."},{"key":"10.1016\/j.antiviral.2014.03.020_b0100","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00535-009-0084-0","article-title":"New therapeutic approaches to hepatitis C virus","volume":"44","author":"Sakamoto","year":"2009","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2014.03.020_b0105","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1128\/JVI.03312-13","article-title":"Inhibition of hepatitis C virus production by aptamer for core protein","volume":"88","author":"Shi","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.020_b0110","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.tibtech.2011.06.009","article-title":"Molecular aptamers for drug delivery","volume":"29","author":"Tan","year":"2011","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.antiviral.2014.03.020_b0115","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nature03580","article-title":"Structure of zinc-binding domain of an essential component of the hepatitis virus replicase","volume":"435","author":"Tellinghuisen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2014.03.020_b0120","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1128\/JVI.00328-07","article-title":"Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein","volume":"82","author":"Tellinghuisen","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.020_b0125","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2014.03.020_b0130","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1268","article-title":"Production of infectious hepatitis C virus in tissue culture from a cloned viral genome","volume":"11","author":"Wakita","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2014.03.020_b0135","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1172\/JCI45876","article-title":"Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using C4 aptamer-siRNA chimeras","volume":"121","author":"Wheeler","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2014.03.020_b0140","doi-asserted-by":"crossref","first-page":"e27552","DOI":"10.1371\/journal.pone.0027552","article-title":"Innate immune response of primary human hepatocytes with hepatitis C viral infection","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2014.03.020_b0145","doi-asserted-by":"crossref","first-page":"e64932","DOI":"10.1371\/journal.pone.0064932","article-title":"2-Octynoic acid inhibits hepatitis C virus infection through activation of AMP-activated protein kinase","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2014.03.020_b0150","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1073\/pnas.0510727103","article-title":"Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells","volume":"103","author":"Yi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.03.020_b0155","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in vitro","volume":"102","author":"Zhong","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.03.020_b0160","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1128\/JVI.77.9.5493-5498.2003","article-title":"Interleukin-1 inhibits hepatitis C virus subgenomic RNA replication by activation of extracellular regulated kinase pathway","volume":"77","author":"Zhu","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.03.020_b0165","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1053\/jhep.2003.50184","article-title":"Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line","volume":"37","author":"Zhu","year":"2003","journal-title":"Hepatology"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214000941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214000941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T23:56:49Z","timestamp":1538697409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214000941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":33,"alternative-id":["S0166354214000941"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.03.020","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of hepatitis C virus infection by NS5A-specific aptamer","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}